About PAK BioSolutions
PAK BioSolutions is a private company based in Vienna, Virginia, incorporated in 2019 in Delaware. It has reported $5,030,000 raised in two offerings on Form D since July 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | Jun 26, 2024 | $5,000,000of $8.4M target | 2 | $2.5M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 18, 2019 | Jul 1, 2019 | $30,000of $300K target | 3 | $10,000 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $5,030,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PAK BioSolutions's Form D filed Jun 26, 2024.
JP
Joanna Pezzini
President and director
DK
Daniel Kidle
Director
Also a director at Akadeum Life Sciences and BrightSpec and a managing partner, arboretum ventures and director at Enumera Molecular.
KB
Kevin Hill-Byrne
Vice President and director
CP
Charles Purtell
Director